HER2-positive solid tumors - Specialty Pharmacy Continuum

×

ADVERTISEMENT

Register Log in

FDA Approves First Fibromyalgia Treatment in 15 Years

AUGUST 21, 2025

Can Manufacturer and Payor Incentives Align?

AUGUST 21, 2025

Partnership on SDOH Bolsters Rheumatoid Arthritis Outcomes

AUGUST 20, 2025

HER2-positive solid tumors

Enhertu Approved for Unresectable or Metastatic HER2-positive Solid Tumors

The FDA granted accelerated approval to fam-trastuzumab Enhertu for adult patients with unresectable or metastatic ...

APRIL 10, 2024

Load more

Check out our new Clinical tab!

We've added an exciting new feature to our website. Click on "Clinical" in the navbar to explore!

The following result is from the NPI Registry Public Search database. You can click on the NPI number to view detailed information and verify its accuracy. If your NPI is not found in this search, you can try searching again using the form below. If you have difficulty finding your NPI number please contact us at web@mcmahonmed.com

First Name

Last Name

OR

Organization/Institution

State

NPI	Name	Organization/ Institution	State	Zip Code	Taxonomy	Credential	Select